Integrated Wealth Concepts’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.86M Buy
29,186
+28,017
+2,397% +$5.8M 0.05% 377
2025
Q4
$241K Sell
1,169
-27,787
-96% -$5.55M ﹤0.01% 1429
2025
Q3
$5.19M Sell
28,956
-1,056
-4% -$180K 0.05% 369
2025
Q2
$4.84M Sell
30,012
-1,279
-4% -$204K 0.05% 342
2025
Q1
$5.32M Buy
31,291
+587
+2% +$102K 0.06% 299
2024
Q4
$5.1M Buy
30,704
+114
+0.4% +$19.5K 0.06% 292
2024
Q3
$5.26M Sell
30,590
-546
-2% -$90.4K 0.06% 276
2024
Q2
$4.79M Sell
31,136
-701
-2% -$105K 0.07% 273
2024
Q1
$4.9M Sell
31,837
-732
-2% -$112K 0.07% 270
2023
Q4
$5.15M Sell
32,569
-2,318
-7% -$333K 0.08% 235
2023
Q3
$5.11M Sell
34,887
-109
-0.3% -$16.6K 0.09% 226
2023
Q2
$5.36M Sell
34,996
-2,133
-6% -$333K 0.09% 221
2023
Q1
$5.76M Buy
37,129
+34,959
+1,611% +$5.49M 0.12% 179
2022
Q4
$334K Sell
2,170
-1,662
-43% -$245K 0.01% 782
2022
Q3
$506K Hold
3,832
0.02% 588
2022
Q2
$519K Sell
3,832
-8,336
-69% -$1.15M 0.02% 593
2022
Q1
$1.81M Buy
12,168
+2,287
+23% +$338K 0.06% 280
2021
Q4
$1.6M Sell
9,881
-2,357
-19% -$381K 0.05% 301
2021
Q3
$2.03M Buy
12,238
+70
+0.6% +$12K 0.07% 245
2021
Q2
$2.1M Buy
12,168
+8,885
+271% +$1.47M 0.07% 212
2021
Q1
$527K Buy
3,283
+1,051
+47% +$180K 0.02% 462
2020
Q4
$375K Buy
+2,232
New +$362K 0.02% 472

Other funds holding FBT

Integrated Wealth Concepts's FBT Position: Q1 2026 in Review

Integrated Wealth Concepts increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2,397% in Q1 2026, buying an estimated $5.8M and bringing the position to 29,186 shares worth $5.86M. The position accounts for 0.05% of the portfolio, ranked #377.

Integrated Wealth Concepts first reported a position in FBT in Q4 2020 and has held it in 22 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Integrated Wealth Concepts held 29,186 shares of First Trust NYSE Arca Biotechnology Index Fund worth $5.86M as of Q1 2026.
  • Integrated Wealth Concepts bought 28,017 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $5.8M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of Integrated Wealth Concepts's portfolio in Q1 2026, its #377 holding.
  • Integrated Wealth Concepts first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and has held it in 22 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.